Spred-3 mutation and Ras/Raf/MAPK activation confer acquired resistance to EGFR tyrosine kinase inhibitor in an EGFR mutated NSCLC cell line
Sign Up to like & getrecommendations! Published in 2020 at "Translational cancer research"
DOI: 10.21037/tcr.2020.03.05
Abstract: Department of Thoracic Medical Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China; Fujian Provincial Key Laboratory of Translation Cancer Medicine, Fuzhou 350014, China; Fujian Provincial Key Laboratory of Tumor Biotherapy, Fujian… read more here.
Keywords: cancer hospital; fuzhou 350014; cancer; 350014 china ... See more keywords